

HY-155801 · 50 mg
MedChemExpress · Cat: HY-155801
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/crx-527.htmlDescription
CRX 527 is a ligand of TLR4 and also serves as an adjuvant for peptide-based cancer vaccines, showing potential to enhance anti-tumor immune responses. CRX 527 can also induce HSC differentiation, increase the proportion and quantity of LSK cells, and promote their differentiation into macrophages, activating immune defense and protecting intestinal epithelium from radiation damage.







